Quanterix QTRX 深 沪
已收盘 11-07 16:00:00 美东时间
4.94
-0.050
-1.00%
华盛通- 最 高5.00
- 今 开4.92
- 成交量 42.93万股
- 最 低 4.84
- 昨 收 4.99
- 总市值 1.92亿
- 52周最高 13.005
- 市盈率 静 --
- 换手率 1.10%
- 52周最低 4.05
- 委 比 89.61%
- 总股本 3885.49万
- 历史最高 92.57
- 量 比 0.95
- 振 幅 3.21%
- 历史最低 4.05
- 每 手 1
- 风险率 2.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quanterix Q3 Earnings Preview
Quanterix (QTRX) is scheduled to announce Q3 earnings results on Monday, November 10th, after market close. The consensus EPS Estimate is -$0.53 and the consensus Revenue Estimate is $37.84M. Over the...
11-08 06:35
Earnings Preview For Quanterix
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on ...
11-08 03:05
Quanterix Approves Key Governance Changes at Annual Meeting
Quanterix ( ($QTRX) ) just unveiled an update. On September 29, 2025, Quanterix...
10-03 04:48
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test
Shares of Quanterix Corp. are up ~4% in Wednesday morning trading after CMS' recently released preliminary Clinical Lab Fee Schedule listed the company's LucentAD Alzheimer blood biomarker test priced...
09-10 23:56
31起并购、超两千亿交易！2025年，仪器巨头为何逆势“买买买”？
导读：截至8月11日，科学仪器行业共发生31起并购交易，公开披露交易总额超2206亿元。与去年同期相比，呈现出“量减价增”的显著特征，科学仪器资本运作市场再度升...
08-15 11:55
A Preview Of Bionano Genomics's Earnings
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings rep...
08-14 02:02
A Look Ahead: Rapid Micro Biosystems's Earnings Forecast
Rapid Micro Biosystems (NASDAQ:RPID) is gearing up to announce its quarterly ea...
08-12 02:01
Canaccord Genuity Downgrades Quanterix to Hold, Lowers Price Target to $5
Canaccord Genuity analyst Kyle Mikson downgrades Quanterix (NASDAQ:QTRX) from Buy to Hold and lowers the price target from $12 to $5.
08-11 18:37
Quanterix Adopts New Bylaws Amid Financial Challenges
An update from Quanterix ( ($QTRX) ) is now available. On August 5, 2025, Quant...
08-08 05:47
Quanterix Q2 EPS $(0.77) Misses $(0.45) Estimate, Sales $24.476M Miss $28.170M Estimate
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.45) by 72.26 percent. This is a 305.26 percent decrease over losses of $(0.19) per share from the
08-08 04:28
